Produktinformation
- 2,4,6-Triiodo-3,5-bis(acetylamino)-N-methyl-N-[[methyl(2,3,4,5,6-pentahydroxyhexyl)amino]carbonylmethyl]benzamide
- Iosarcol [INN]
- 3,5-Diacetamido-2,4,6-triiodo-N-methyl-N((methyl(D-gluco-2,3,4,5,6-pentahydroxyhexyl)carbamoyl)methyl)benzamide
- Iosarcolum
- Iosarcolum [INN-Latin]
- Unii-4Dsd895Ogc
- 1-[{N-[3,5-bis(acetylamino)-2,4,6-triiodobenzoyl]-N-methylglycyl}(methyl)amino]-1-deoxyhexitol
- 1-[{N-[3,5-bis(acetylamino)-2,4,6-triiodobenzoyl]-N-methylglycyl}(methyl)amino]-1-deoxy-D-glucitol
Iosarcol is a diagnostic agent that is administered intravenously. It is used for the detection of cancer and has been shown to be effective in imaging tumors and identifying the target tissue. Iosarcol is also used as a contrast agent in angiography, which can be helpful in diagnosing heart disease or narrowing of blood vessels. Iosarcol has been shown to bind to calcium ions in cells and can be used as an indicator of intracellular calcium concentration. Iosarcol is a high viscosity liquid with excipients such as human serum albumin, dextrose, and sodium chloride.